Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02783274 · ClinicalTrials.gov registry record · NA

Actis Total Hip System 2 Year Follow-up

A NA study of Rheumatoid Arthritis and Osteoarthritis, sponsored by DePuy Orthopaedics.

Completed
Registry status
NA
Development phase
266
Enrollment target
9
Study locations

NCT02783274: Completed NA study of Rheumatoid Arthritis and Osteoarthritis, sponsored by DePuy Orthopaedics.

NCT02783274 is a NA study of Rheumatoid Arthritis and Osteoarthritis that has completed, run by DePuy Orthopaedics. The registered enrollment target is 266 participants, below the 4,689-participant average among 197 other Rheumatoid Arthritis trials with a reported enrollment target (94% lower). The trial reports 9 study locations across 9 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02783274, a NA study of Rheumatoid Arthritis and Osteoarthritis, has completed, sponsored by DePuy Orthopaedics.

COMPLETED
Registry status
NA
Development phase
266 participants
Enrollment target
9
Study locations

Study Summary

Two-year (2 year) information regarding the performance of the commercially available Actis™ Total Hip System in order to obtain and evaluate the clinical outcomes on a series of cementless primary total hip arthroplasty (THA) and hemi-hip arthroplasty procedures using clinical, radiographic and device and procedure related adverse event assessments.

Primary Outcome

The Harris Hip Score (HHS) is a standardized tool used to evaluate hip pain, function, and mobility. The HHS is score from 0 to 100, with higher scores indicating better outcomes. A score of less than 70 is considered poor, 70-80 is fair, 80-90 is good, 90-100 is excellent.

Conditions Studied

Rheumatoid Arthritis Osteoarthritis Traumatic Arthritis Avascular Necrosis of the Femoral Head Congenital Hip Dysplasia Certain Cases of Ankylosis Acute Traumatic Fracture of the Femoral Head or Neck Non-union of Femoral Neck Fractures Certain High Sub-Capital & Femoral Neck Fractures in Elderly

Interventions

  • DEVICE Actis Total Hip System

Study Locations (9)

Kentucky

  • - Louisville

Massachusetts

  • - Boston

Minnesota

  • - Rochester

New Hampshire

  • - Lebanon

New York

  • - New York

North Carolina

  • - Charlotte

Pennsylvania

  • - Philadelphia

Texas

  • - Austin

Trial Details

FieldValue
Enrollment Target 266 participants
Start Date 2016-07-01
Est. Completion 2024-03-13
Phase NA
DePuy Orthopaedics

38 total trials

What the finished NCT02783274 record still lists

NCT02783274 is an interventional study that assigns participants to a tested intervention. The registered 266 participants enrollment target is mid-sized for trials with a published cap, below the 4,689-participant average among 197 other Rheumatoid Arthritis trials with a reported enrollment target (94% lower).

The record links to 9 conditions, with Rheumatoid Arthritis appearing as the primary indexed condition, and to 1 intervention - of which Actis Total Hip System is the first listed.

NCT02783274 lists 9 locations in 9 states (Kentucky, Massachusetts, Minnesota).

Frequently Asked Questions

What is clinical trial NCT02783274 about?

NCT02783274 is a clinical study titled "Actis Total Hip System 2 Year Follow-up". Two-year (2 year) information regarding the performance of the commercially available Actis™ Total Hip System in order to obtain and evaluate the clinical outcomes on a series of cementless primary total hip arthroplasty (THA) and hemi-hip arthroplasty procedures using clinical, radiographic and dev...

What is the current status of trial NCT02783274?

This trial is currently completed. It is a NA study. The enrollment target is 266 participants. The study started on 2016-07-01. Estimated completion is 2024-03-13.

What conditions does trial NCT02783274 study?

This clinical trial studies the following conditions: Rheumatoid Arthritis, Osteoarthritis, Traumatic Arthritis, Avascular Necrosis of the Femoral Head, Congenital Hip Dysplasia.

What interventions are being tested in trial NCT02783274?

The interventions under investigation include: Actis Total Hip System (DEVICE).

Who is sponsoring clinical trial NCT02783274?

This trial is sponsored by DePuy Orthopaedics, which has 38 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02783274 being conducted?

This trial has 9 study locations across Kentucky, Massachusetts, Minnesota, New Hampshire, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Rheumatoid Arthritis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02783274's enrollment target sits among peer trials

266 68th of 197 higher than 129 of 197 other Rheumatoid Arthritis trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Rheumatoid Arthritis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05098652 · 266 participants · NA

    Coaching Dementia Caregivers to Master Care-Resistant Behavior

  • NCT06088277 · 266 participants · NA

    Texting to Reduce Human Immunodeficiency Virus (HIV) Risk

  • NCT06261814 · 266 participants · Phase 2

    Contrast Enhanced Ultrasound to Evaluate Response to Chemoembolization in Patients With Liver Tumors

  • NCT06312124 · 266 participants · NA

    A Study of Opportunistic Salpingectomy to Prevent Ovarian Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Related registry views

Source: ClinicalTrials.gov NCT02783274, the US trial registry maintained by the National Library of Medicine. NCT02783274 (mid enrollment · multi site footprint · completed) retrieved and formatted by PlainTrial, see methodology.